Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.16 and traded as high as $0.33. Cell MedX shares last traded at $0.32, with a volume of 3,953 shares changing hands.
Cell MedX Price Performance
The company has a 50-day moving average price of $0.37 and a 200 day moving average price of $0.16.
Cell MedX Company Profile
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.
Further Reading
- Five stocks we like better than Cell MedX
- Top Biotech Stocks: Exploring Innovation Opportunities
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- Most Volatile Stocks, What Investors Need to Know
- 3 Buy-and-Hold Stocks for Long-Term Growth
- How to trade using analyst ratings
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.
